SOPHIA GEVOY: Open Payments
NPI 1952909467 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 27 payments from 9 companies in 2025. Trend: 2023 $100 · 2024 $467 · 2025 $685
Food & beverage: $619Education: $66
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $273 |
| ABBVIE INC. | 5 | $123 |
| Janssen Biotech, Inc. | 2 | $80 |
| PFIZER INC. | 4 | $76 |
| LEO Pharma Inc. | 3 | $56 |
| GENZYME CORPORATION | 1 | $32 |
| Lilly USA, LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Organon LLC | 1 | $11 |
Products named: OPZELURA, SKYRIZI, TREMFYA, CIBINQO, ADBRY, DUPIXENT, TALTZ, COSENTYX.
Industry payments across FL — which companies pay providers there.
